Related Experiment Video
Updated: Sep 28, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
Bernd Berwanger1, Oliver Hartmann, Eckhard Bergmann
1Institute for Molecular Biology and Tumor Research, Emil-Mannkopff-Strasse 2, 35037 Marburg, Germany.
Abstract:
Tumor stage, age of patient, and amplification of MYCN predict disease outcome in neuroblastoma. To gain insight into the underlying molecular pathways, we have obtained expression profiles from 94 primary neuroblastoma specimens. Advanced tumor stages show a characteristic expression profile that includes downregulation of multiple genes involved in signal transduction through Fyn and the actin cytoskeleton. High expression of Fyn and high Fyn kinase activity are restricted to low-stage tumors. In culture, expression of active Fyn kinase induces differentiation and growth arrest of neuroblastoma cells. Expression of Fyn predicts long-term survival independently of MYCN amplification. Amplification of MYCN correlates with deregulation of a distinct set of genes, many of which are target genes of Myc. Our data demonstrate a causal role for Fyn kinase in the genesis of neuroblastoma.
Insights
Fyn kinase promotes neuroblastoma cell differentiation and growth arrest, indicating its role in tumor suppression. High Fyn expression predicts better survival, independent of MYCN amplification in neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma outcomes are predicted by tumor stage, patient age, and MYCN amplification.
- Understanding molecular pathways is crucial for neuroblastoma research.
Purpose of the Study:
- To investigate the molecular pathways associated with neuroblastoma progression.
- To determine the role of Fyn kinase in neuroblastoma development and patient survival.
Main Methods:
- Gene expression profiling of 94 primary neuroblastoma specimens.
- Analysis of Fyn kinase expression, activity, and its effect on neuroblastoma cell lines.
- Correlation of Fyn expression and MYCN amplification with clinical outcomes.
Main Results:
- Advanced tumor stages exhibit downregulated genes in Fyn signaling and actin cytoskeleton pathways.
- High Fyn expression and kinase activity are observed in low-stage neuroblastoma.
- Fyn kinase expression predicts long-term survival independently of MYCN amplification.
- MYCN amplification correlates with deregulation of Myc target genes.
Conclusions:
- Fyn kinase plays a causal role in neuroblastoma genesis.
- Fyn kinase activity induces neuroblastoma cell differentiation and growth arrest.
- Fyn kinase is a potential therapeutic target for improving neuroblastoma patient outcomes.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
